Close Menu

stock downgrade

NEW YORK (GenomeWeb News) – Investment firm ISI Group today downgraded shares of Cepheid to Sell, saying it expects the Sunnyvale, Calif. molecular diagnostics firm's base business to slow due to increased competition in the hospital-acquired infection space.

NEW YORK (GenomeWeb News) – Investment bank Piper Jaffray has downgraded Illumina to Neutral from Overweight and also has cut its price target on the stock.

NEW YORK (GenomeWeb News) – Investment bank Jefferies today downgraded Myriad Genetics and Cepheid to Hold from Buy.

NEW YORK (GenomeWeb News) – Investment bank Goldman Sachs today upgraded shares of Quest Diagnostics and Laboratory Corporation of America, but downgraded Sigma-Aldrich.

NEW YORK (GenomeWeb News) – Citing a recent run up in Life Technologies' stock fueled by speculation that it may be positioning itself to be bought, investment bank Cowen & Co. today downgraded the Carlsbad, Calif.-based firm to Neutral from Outperform.

NEW YORK (GenomeWeb News) – Investment bank Cowen and Co. has downgraded the stocks of Luminex and Qiagen to Underperform from Neutral.

NEW YORK (GenomeWeb News) – Leerink Swann downgraded Waters today to Market Perform, saying the company could be challenged by the macroeconomic environment and softer end-markets, as well as increasing competition for its products and services.

NEW YORK (GenomeWeb News) – Wall Street analysts took a mixed view of Myriad Genetics today following the announcement on Friday by the US Supreme Court that it would review a lawsuit ch

NEW YORK (GenomeWeb News) – Piper Jaffray today downgraded shares of Sequenom to Neutral, saying that its fight to stay ahead of competitors in the non-invasive fetal chromosome abnormalities testing space may result in greater costs to the company, while its ability to get reimbursement remains

NEW YORK (GenomeWeb News) – RW Baird today downgraded Complete Genomics to Neutral from Outperform on Illumina's introduction of its rapid Individual Genome Sequencing service with a turnaround time of as little as two weeks.

Pages

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.